For the past decade, the pharmaceutical industry has been under pressure to improve
efficiency, as rising costs outpaced the development of new pharmaceuticals.[1] A growing …

Innovation in the pharmaceutical industry has been limited for a long time to the research
and development of new active compounds; meanwhile, the structure of the production …

Characteristics of crystal quality, including crystal size distribution, size, morphology,
polymorphism and chirality, have been established as important indicators of crystalline …

Crystallization is an important unit operation in the pharmaceutical industry. At present, most
pharmaceutical crystallization processes are performed in batches. However, due to product …

Seeding is a significant but challenging task for optimizing crystallization process operation,
product quality, and process efficiency. With the development of modern crystallization …

Recently, the bioconversion of biomass into biofuels and biocommodities has received
significant attention. Although green technologies for biofuel and biocommodity production …

Secondary nucleation can bring the crystallization process into a more easily controlled
state, and it is playing an important role in controlling crystal size distribution, polymorphism …

Pharmaceutical cocrystals represent an emergent class of successful materials designed
based on crystal engineering principles, in which the limitations of the extant drugs are …

A novel continuous crystallizer design is described with the potential to provide improved
control of crystal properties, improved process reproducibility, and reduced scale-up risk …

Protein crystals have many important applications in many fields, including pharmaceutics.
Being more stable than other formulations, and having a high degree of purity and …